Atrium Therapeutics (RNA) Stock Fundamentals & Financials

Atrium Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Kathleen Gallagher, with a market cap of $162.5M.

Market cap

$162.5M-97.2%

We’re still putting together Atrium Therapeutics’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move Atrium Therapeutics up the queue, and we’ll analyze its filings next.